KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) EBITDA (2016 - 2025)

Historic EBITDA for Global Medical REIT (GMRE) over the last 10 years, with Q3 2025 value amounting to $4.0 million.

  • Global Medical REIT's EBITDA fell 419.5% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year decrease of 2376.05%. This contributed to the annual value of $15.4 million for FY2024, which is 2396.42% down from last year.
  • Latest data reveals that Global Medical REIT reported EBITDA of $4.0 million as of Q3 2025, which was down 419.5% from $3.5 million recorded in Q2 2025.
  • Global Medical REIT's 5-year EBITDA high stood at $10.0 million for Q3 2021, and its period low was $1.9 million during Q4 2024.
  • Its 5-year average for EBITDA is $5.9 million, with a median of $5.3 million in 2022.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 26067.25% in 2021, then crashed by 6584.09% in 2024.
  • Over the past 5 years, Global Medical REIT's EBITDA (Quarter) stood at $8.9 million in 2021, then crashed by 40.83% to $5.3 million in 2022, then grew by 4.54% to $5.5 million in 2023, then plummeted by 65.84% to $1.9 million in 2024, then soared by 109.16% to $4.0 million in 2025.
  • Its EBITDA was $4.0 million in Q3 2025, compared to $3.5 million in Q2 2025 and $5.1 million in Q1 2025.